| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.10. | Profound Medical Corp (2): Profound Medical upbeat about Busch Center results | 2 | Stockwatch | ||
| 07.10. | Profound Medical Corp (2): Profound estimates Q3 revenue of $5.2-million (U.S.) | 2 | Stockwatch | ||
| 07.10. | Profound Medical achieves record prelim revenue for third quarter | 1 | Seeking Alpha | ||
| 07.10. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.10. | Profound Medical Corp.: Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter | 81 | GlobeNewswire (Europe) | TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable... ► Artikel lesen | |
| 25.09. | Raymond James bestätigt "Outperform"-Rating für Profound Medical | 2 | Investing.com Deutsch | ||
| 25.09. | Profound Medical stock rating reiterated at Outperform by Raymond James | 4 | Investing.com | ||
| 23.09. | Profound Medical Corp (2): Profound Medical talks Tulsa use by Texas Prostate | 1 | Stockwatch | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 23.09. | Profound Medical Corp.: Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment | 2 | GlobeNewswire (USA) | ||
| 19.08. | Profound Medical is a buy, Leede says | 5 | Cantech Letter | ||
| 15.08. | Profound Medical targets 70-75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence | 2 | Seeking Alpha | ||
| 14.08. | Profound Medical Corp.: Profound Medical Announces Second Quarter 2025 Financial Results | 158 | GlobeNewswire (Europe) | TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable... ► Artikel lesen | |
| 14.08. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.07. | Profound Medical Corp (2): Profound Medical to release Q2 results Aug. 14 | 1 | Stockwatch | ||
| 10.06. | Profound Medical Corp (2): Profound completes first BPH treatment with Tulsa-Pro | 1 | Stockwatch | ||
| 10.06. | Profound Medical Corp.: Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction | 1 | GlobeNewswire (USA) | ||
| 04.06. | Profound Medical Corp (2): Profound Medical names ex-NFLer Wheeler as ambassador | 2 | Stockwatch | ||
| 04.06. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.06. | Profound Medical Corp.: Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO | 1 | GlobeNewswire (USA) | ||
| 15.05. | Profound Medical Corp (2): Profound Medical shareholders approve AGM resolutions | 1 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,290 | -2,26 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,640 | -1,26 % | DAX-Check LIVE: BMW, Auto1 Group, Evotec, Fresenius, Kontron, Siemens Healthineers, Vonovia | Nach dem freundlichen Auftakt in den Börsenmonat November geriet der DAX gestern deutlich unter Druck. Zwischenzeitlich rutschte der Leitindex im Tagestief um rund zwei Prozent ab. Auf dem niedrigeren... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,400 | -1,52 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 24,020 | -4,38 % | PAUKENSCHLAG bei Gerresheimer! KAUFCHANCE bei TKMS und Kobo Resources! | Gold- und Rüstungsaktien haben in der vergangenen Woche ihre Verschnaufpause fortgesetzt. Dies bietet Chancen. Bei TKMS kauft ein Insider und Analysten sehen 25 % Kurspotenzial. Zudem sehen sie weiteres... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,140 | +1,72 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,460 | +1,68 % | Carl Zeiss Meditec-Aktie sorgt für Spannung - steht am Montag ein Richtungswechsel bevor?!! | ||
| PROGYNY | 22,370 | +24,21 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| UNITEDHEALTH | 280,55 | +0,14 % | UNITEDHEALTH GROUP INC steht vor einer explosiven Bewegung | ||
| OTTOBOCK | 68,25 | +0,37 % | Ottobock-Aktie im Rampenlicht - Marktbeobachter warnen vor plötzlicher Trendwende!!! | ||
| AIRSCULPT TECHNOLOGIES | 6,130 | -41,84 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results | MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,930 | +2,01 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 35,540 | +0,17 % | Zahlen veröffentlicht: Hims & Hers übertrifft Umsatzprognosen: Kommt ein Deal mit Novo Nordisk? | © Foto: Dall-EHims & Hers Health setzt auf Expansion, Diagnostik und einen möglichen Deal mit dem dänischen Pharmariesen Novo Nordisk. Die Aktie steigt nachbörslich deutlich.Das US-amerikanische Telemedizinunternehmen... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,810 | -13,27 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Agreement to Acquire IRRAS | Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment... ► Artikel lesen | |
| GENEDX | 139,95 | +0,67 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS | 4,450 | -28,57 % | Morning Market Movers: Motorsport Games, Davis Commodities, Eledon Pharmaceuticals, Treace Medical Concepts See Big Swings | BEIJING (dpa-AFX) - At 7:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |